✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹30,150 Cr.
P/E
229.98
About
Laurus Labs Limited is a leading player in the global pharmaceutical industry, offering a wide range of Active Pharma Ingredients (API), Generic Finished dosage forms (FDF), and Contract Research serv… Read more
Laurus Labs Limited is a leading player in the global pharmaceutical industry, offering a wide… Read more
Low
361
52W Range
High
593
  • Laurus Labs
  • Neuland Laboratories
  • Granules India
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

API Break-Up

Operational Metrics

    Select a Metric
    • US DMF Filings (.)
    • Number of ANDA's Filed in Europe
    • Number of ANDA's Approved in Europe
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Number of ANDA's Approved by Canada
    • Number of ANDA's Filed in Canada
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Suppliers
    • Neogen Chemicals Ltd.
    • HLE Glascoat Ltd.
    • Tatva Chintan Pharma Chem Ltd.
    • Chemcon Speciality Chemicals Ltd.
    Customers
    • Aurobindo Pharma Ltd.
    • Cipla Ltd.
    • Natco Pharma Ltd.
    • Strides Pharma Science Ltd.
    • Sun Pharmaceutical Industries Ltd.
    FAQs on Laurus Labs Ltd. Business

    Laurus Labs Limited offers a wide range of Active Pharma Ingredients (API), Generic Finished dosage forms (FDF), and Contract Research services globally, focusing on areas like anti-retroviral, Hepatitis C, and Oncology drugs through continuous innovation.

    Laurus Labs major competitors are Neuland Laboratories, Granules India, Alivus Life Sciences, AMI Organics, Shilpa Medicare, Supriya Lifescience, Aarti Pharmalabs.
    Market Cap of Laurus Labs is ₹30,150 Crs.
    While the median market cap of its peers are ₹8,672 Crs.

    Laurus Labs seems to be less financially stable compared to its competitors.
    Altman Z score of Laurus Labs is 5.74 and is ranked 7 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Dec Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis